Patents by Inventor Ralph Eckenberg

Ralph Eckenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES OF IL-2
    Publication number: 20100273723
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: January 21, 2010
    Publication date: October 28, 2010
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
    Patent number: 7704490
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: April 27, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
    Patent number: 7662368
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: February 16, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Publication number: 20070048302
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: July 28, 2006
    Publication date: March 1, 2007
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Patent number: 7101965
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: September 5, 2006
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20060018873
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof
    Patent number: 6929791
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: August 16, 2005
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Patent number: 6825334
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: November 30, 2004
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20040202661
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: December 5, 2003
    Publication date: October 14, 2004
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • DNA encoding peptides of IL-2
    Patent number: 6596853
    Abstract: The invention relates to the use as therapeutic agents of IL-2 peptides and derivatives having biological activity and anti-IL-2 antibodies which mimic or modulate the biological activities of IL-2. The invention also relates to DNA sequences encoding the IL-2 peptides, and to methods of using the IL-2 peptides and derivatives and anti-IL-2 antibodies to modulate or mimic or antagonize the biological activities of IL-2 in vivo and to assay for the presence and activity of the IL-2 receptor.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: July 22, 2003
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20020044935
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: February 6, 2001
    Publication date: April 18, 2002
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
    Patent number: 6168785
    Abstract: The invention relates to the use as therapeutic agents of IL-2 peptides and derivatives having biological activity and anti-IL-2 antibodies which mimic or modulate the biological activities of IL-2. The invention also relates to DNA sequences encoding the IL-2 peptides, and to methods of using the IL-2 peptides and derivatives and anti-IL-2 antibodies to modulate or mimic or antagonize the biological activities of IL-2 in vivo and to assay for the presence and activity of the IL-2 receptor.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: January 2, 2001
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Jean-Claude Mazie